Abstract:BACKGROUND Uterine fibroids are benign tumors that originate from smooth muscle cells of the uterus. It is the most common gynecological disorder, affecting up to 80% of women of reproductive age. Uterine fibroids can cause various symptoms such as abnormal uterine bleeding, pelvic pain, infertility, and pregnancy complications. The treatment options for uterine fibroids include medical therapy, surgical intervention, and minimally invasive techniques. AIM To compare ovarian function of women with uterine fibroids who did or did not undergo uterine artery embolization (UAE). METHODS This prospective cohort study enrolled 87 women with symptomatic uterine fibroids who underwent UAE, and 87 women with the same symptoms who did not undergo UAE but received conservative management or other treatments. The two groups were matched for age, body mass index, parity, and baseline characteristics of uterine fibroids. The primary outcome was ovarian function that was evaluated by serum levels of follicle-stimulating hormone (FSH), luteinizing hormone (LH), estradiol (E2), and anti-Müllerian hormone (AMH), as well as ovarian reserve tests, such as antral follicle count (AFC) and ovarian volume (OV). The secondary outcome was fertility that was evaluated based on the menstrual cycle, ovulation, conception, pregnancy, and delivery. The participants were followed-up for 36 months and assessed at 1, 3, 6, 12, 24, and 36 months after treatment. RESULTS The study found that the most common minor complication of UAE was postembolization syndrome in 73.6% of women, resolving within a week. No significant differences were observed between the UAE group and the control group in serum levels of reproductive hormones (FSH, LH, E2, AMH) and ovarian reserve indicators (AFC, OV) at any point up to 36 months post-treatment. Additionally, there were no significant differences in conception, pregnancy, or delivery rates, with the average time to conception and gestational age at delivery being similar between the two groups. Birth weights were also comparable. Finally, there was no significant correlation between ovarian function, fertility indicators, and the type or amount of embolic agent used or the change in fibroids post-treatment. CONCLUSION UAE resulted in significantly positive pregnancy outcomes, no adverse events post-treatment, and is a safe and effective treatment for uterine fibroids that preserves ovarian function and fertility.

Comparison of the uterine artery angiography images and complications between uterine fibroids and adenomyoma after embolization

An Analysis of the Related Problems in Uterine Artery Embolization for Uterine Fibroids and Adenomyosis

Clinical Analysis of the Selective Uterine Arterial Embolization in Treating Uterine Leiomyoma

Analysis of Uterine Artery Embolization for the Treatment of Uterine Leiomyomas

Selective Uterine Artery Embolization for Treatment of Symptomatic Uterine Fibroids

Uterine Artery Embolization for Treatment of Adenomyosis: Midterm Results

Outcomes In Adenomyosis Treated With Uterine Artery Embolization Are Associated With Lesion Vascularity: A Long-Term Follow-Up Study Of 252 Cases

The Effectiveness and Predictive Factors for the Outcomes of Adenomyosis after Uterine Artery Embolization

The feasibility of trans-abdominal biopsy by ultrasound guiding during uterine artery embolization for benign diseases of uterus

Uterine Artery Embolization Versus Surgery for Symptomatic Uterine Fibroids: a Randomized Controlled Trial and a Meta-Analysis of the Literature

Clinical Significance of Serum VEGF, IGF-1 and CA125 Levels in the Uterine Artery Embolization Treatment for Uterine Adenomyosis

Observing pregnancy after blood vessel interventional therapy for adenomyosis

Impact of uterine artery embolization on ovarian function and pregnancy outcome after uterine-fibroids treatment: A prospective study

Recent Curative Effect of Adenmyosis by Interventional Technique Through Uterine Artery

Uterine Arterial Embolization for the Treatment of Uterine Leiomyomas:Its Dynamic Imaging Monitoring and Therapeutic Mechanism

Factors associated with dysmenorrhoea and menorrhagia improvement in patients with adenomyosis after uterine artery embolisation

Efficacy of uterine arterial embolization in symptomatic uterine leiomyomata

Transcatheter Uterine Arterial Embolization for the Treatment of Uterine Fibroid

Two Different Embolic Agents in the Treatment of Uterine Arterial Embolization for Symptomatic Fibroids

An Imageological Study of the Mechanism of Uterine Fibroids Embolization

The Value of Transvaginal Color Doppler Energy Sonography in Uterine Fibroids Embolization